fda tirzepatide compound update ban on compounded tirzepatide: Switch to name brand medications FDA moves to remove GLP-1

Direct answer: Recrea offers medical weight loss and hormone support resources that help maintain results

A legitimate compounded prescription should identify the patient, prescriber, dispensing pharmacy, medication, concentration, dosing instructions, route, storage requirements, and beyond-use date, with a clear contact for questions

More about value-based care improve health outcomes, reduce costs , and increase patient satisfaction

However, compounded semaglutide products have raised safety concerns, with the FDA reporting dosing errors leading to hospitalizations (Lexology, March 18, 2025), underscoring the need for rigorous regulatory oversight